The Congenital Long QT Syndrome. A Mask for Many Faces**Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 9, 2008, Pages 930-932

  Lazzara, Ralph ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL SCN5A; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ARRHYTHMOGENESIS; DISEASE SEVERITY; EDITORIAL; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART DEPOLARIZATION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; PHENOTYPE; POTASSIUM CURRENT; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; SYMPATHETIC TONE; TORSADE DES POINTES;

GENETIC HETEROGENEITY; HUMANS; ION CHANNELS; LONG QT SYNDROME; MUTATION;

EID: 39549099913     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.048     Document Type: Editorial

References (25)

1. Jervell A., and Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J 54 (1957) 59-68
2. Moss A.J., Zareba W., Hall W.J., et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101 (2000) 616-623
3. Schwartz P.J., Priori S.G., Cerrone M., et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long QT syndrome. Circulation 109 (2004) 1826-1833
4. Wang Q., Curran M.E., Splawski I., et al. Positional cloning of a novel potassium channel gene: KVLQTl mutations cause cardiac arrhythmias. Nat Genet 12 (1996) 17-23
5. Curran M.E., Splawski I., Timothy K.W., et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
6. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
7. Splawski I., Tristani-Firouzi M., Lehmann M.H., et al. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 17 (1997) 338-340
8. Abbott G.W., Sesti F., Splawski I., et al. MiRPl forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97 (1999) 175-187
9. Tristani-Firouzi M., Jenson J.L., Donaldson M.R., et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110 (2002) 381-388
10. Splawski I., Timothy K., Sharpe M.L., et al. Ca(V) 1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
11. Locati E.H., Zareba W., Moss A.J., et al. Age and sex-related differences in clinical manifestations in patients with congenital long-AT syndrome: findings from the International LQTS Registry. Circulation 97 (1998) 2237-2244
12. Chiang C.E. Congenital and acquired long QT syndrome: current concepts and management. Cardiol Rev 12 (2004) 1-25
13. Zareba W., Moss A.J., Daubert J.P., et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14 (2003) 337-341
14. Moss A.J., Zareba W., Kaufman E.S., et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105 (2002) 794-799
15. Crotti L., Lundquist A.L., Insolia R., et al. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation 112 (2005) 1251-1258
16. Roden D. Taking the "idio" out of "idiosyncratic": predicting Torsades de pointes. Pace 21 (1998) 1029-1034
17. Volders P.G., Vos M.A., Szabo B., et al. Progress in the understanding of cardiac early afterdepolarizations and Torsades de pointes: time to revise current concepts. Cardiovasc Res 46 (2000) 376-392
18. El-Sherif N., Caref E.B., Yin H., et al. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: tridimensional mapping of activation and recovery patterns. Circulation 79 (1996) 474-492
19. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in long-QT syndrome. N Engl J Med 348 (2003) 1866-1874
20. Priori S.G., Napolitano C., and Schwartz P.J. Low penetrance in the long-QT syndrome: clinical impact. Circulation 99 (1999) 529-533
21. Schwartz P.J., Vanoli E., Crotti L., et al. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. J Am Coll Cardiol 51 (2008) 920-929
22. Brink P.A., Crotti L., Corfield V., et al. Phenotypic variability and unusual clinical severity of congenital long QT syndrome in a founder population. Circulation 112 (2005) 2602-2610
23. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 80-95
24. 2c)-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 275 (2000) 23059-23064
25. Mason D.A., Moore J.D., Green S.A., and Liggett S.B. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674